María Vieito
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 21
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 24
- Cancer Cells and Metastasis 11
- CAR-T cell therapy research 11
- Genetics top 5%
- Glioma Diagnosis and Treatment 16
-
- Cancer Research and Treatments 11
-
- Radiopharmaceutical Chemistry and Applications 9
- Radiomics and Machine Learning in Medical Imaging 9
- Co-authors
- Rafael López‐LópezLaura Muinelo‐RomayMiguel AbalAlicia AbaloMarta Alonso‐NoceloAntonio Gómez‐TatoUrbano AnidoM. Casares de Cal
- Cited by
- Cancer ResearchOncologyGenetics
- Journals
- Nature Medicine (1 paper)Journal of Clinical Oncology (28 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
María Vieito
86 papers receiving 901 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 337
- Oncology 510
- Genetics 189
- Pulmonary and Respiratory Medicine 256
- Immunology 106
Countries citing papers authored by María Vieito
This map shows the geographic impact of María Vieito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Vieito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Vieito more than expected).
Fields of papers citing papers by María Vieito
This network shows the impact of papers produced by María Vieito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Vieito. The network helps show where María Vieito may publish in the future.
Co-authorship network
The 25 scholars most cited alongside María Vieito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 4 | |
| 8 | 2024 | 15 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 0 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2020 | 3 | |
| 17 | 2020 | 0 | |
| 18 | 2020 | 1 | |
| 19 | 2020 | 0 | |
| 20 | 2018 | 5 |
About María Vieito
María Vieito is a scholar working on Oncology, Cancer Research and Genetics, having authored 100 papers that have together received 907 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Cancer Genomics and Diagnostics (21 papers), Glioma Diagnosis and Treatment (16 papers), Cancer Cells and Metastasis (11 papers), Cancer Research and Treatments (11 papers), CAR-T cell therapy research (11 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Radiomics and Machine Learning in Medical Imaging (9 papers). The work is most often cited by research in Cancer Research (337 citations), Oncology (510 citations) and Genetics (189 citations). María Vieito has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Rafael López‐López, Laura Muinelo‐Romay, Miguel Abal, Alicia Abalo, Marta Alonso‐Nocelo, Antonio Gómez‐Tato, Urbano Anido, M. Casares de Cal, Jorge Barbazán and Sonia Candamio. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.